nhs healthcare contracts

Supply Chain Coordination Limited (“NHS Supply Chain”) intends to procure a National Framework Agreement for the supply of Medical Examination Gloves including but not limited to: 6N Examination Gloves: 6N Nitrile Exam Gloves Examination Gloves Specialised Following further review of the category strategy, market landscape, and customer requirements, it has been concluded that Medical Examination Gloves and Surgical Gloves will be procured through separate frameworks. Whilst the original PME notice (2025/S 000-052117) indicated an intention to combine the two categories into a single framework, subsequent analysis identified that they operate as distinct markets with differing customer needs, supply bases, technical specifications, and procurement considerations. In addition, the categories are subject to different commercial models, pricing mechanisms, market dynamics, and contract management requirements. Maintaining separate frameworks will enable a more tailored procurement approach for each category, support effective category management, and better align with customer and market needs. This revised approach is expected to enhance supplier engagement, promote competition, and provide greater flexibility to respond to future market developments and evolving customer demand. We are looking at ways to review the procurement strategy and simplify commercials in terms of agreements and pricing points, rationalise ranges for stocked product. This framework will continue to incorporate sustainability requirements for third party social audits across Medical Examination Gloves. NHS Supply Chain is assessing the most appropriate procurement approach, and the tendering procedures that may be used for future contract awards. The Framework Agreement will be entered into between the Authority and individual Supplier(s). The Authority may purchase goods under the Framework Agreement, which will be made available for purchase by: • any NHS Trust; • any other NHS entity; • any government department, agency or other statutory body (for the avoidance of doubt including local authorities); and/or • any private sector entity active in the UK healthcare sector. The award of a place on the Framework Agreement does not guarantee any commitment by the Authority or its customers to place any orders under the Framework Agreement. To participate in NHS Supply Chain procurements, Tenderers must be registered on the Central Digital Platform (CDP) and have shared their information with NHS Supply Chain via the CDP. The CDP is available at: https://www.gov.uk/findtender Please ensure your details match your account details in Jaggaer, Companies House and CDP. It is the Suppliers responsibility to ensure the account set up in Jaggaer is in the correct company name. For example, if the name has been set up incorrectly or the business has had changes to its organisation we recommend the following: Incorrect Name (such as typo) - Contact Jaggaer via the help options (seen on page after logging in) and explain that the details are incorrect and provide correct details. Company organisation Changes - 2 options: Note: Audit trails need to be maintained in Jaggaer which makes it difficult to allow changes to business that have had significant changes such as merges of businesses or been purchased by other organisations. Option 1: Create a new account with new name (preferred). Option 2: Current account - Contact Jaggaer via the help options (seen on page after logging in) and provide details of the changes (such as a company name change document from companies house). Tenderers must also be registered on Jaggaer, as all tender activity will be conducted through this system. The Tenderer is responsible for ensuring that its Jaggaer account is set up in the correct company name and that all information is kept up to date. Jaggaer can be accessed via https://nhssupplychain.app.jaggaer.com The Authority estimates that, in the first 12 months of the Framework, the total value of purchases will be approximately £125,000,000 excluding VAT. Over the full 48-month term, the estimated total value is approximately £500,000,000 excluding VAT. These values are indicative only and do not constitute any guarantee of business with successful Tenderers. The following requirements are anticipated to apply but are not exhaustive and may be updated in accordance with applicable legislation and/or relevant guidance (please refer to the requirements set out in the ITT): • ISO Certification Tenderers must hold ISO 9001: 2015, ISO 13485:2016 or Medical Device Single Audit Program (MDSAP) certification, accredited by the United Kingdom Accreditation Service (UKAS) or internationally recognised equivalent. The certification must cover all relevant elements of the Tenderer’s and the product(s)’ supply chain, including (but not be limited to) sales, manufacturing, storage and distribution. Acceptable UKAS alternatives are listed at: https://global-aci.org/en/full-members • CE Certification and Declaration of Conformity Where applicable, valid CE Certification and Declarations of Conformity must be submitted at the tender submission stage. • Modern Slavery Statement Tenderers with an annual turnover of £36 million or more must comply with the Modern Slavery Act 2015, publish an annually updated Modern Slavery Statement on their website, and provide a link to that statement. • Modern Slavery Assessment Tool (MSAT) Tenderers must have achieved an MSAT score of 41% or above within 12 months prior to the tender close date. The assessment results must be shared with NHS Supply Chain via the ‘share’ function on the Supplier Registration Service (SRS) Portal, available at: https://supplierregistration.cabinetoffice.gov.uk • Third-party Audit Tenderers must provide evidence of third-party social audits for manufacturing facilities supplying products under the Framework. Audit requirements are expected to include assessment against forced labour risks, including the 11 International Labour Organisation (ILO) Forced Labour Indicators. NHS Supply Chain continues to review its responsible sourcing approach and, as such, third-party audit requirements may be developed further during the procurement process. Further details will be provided within the ITT documentation. • Evergreen Sustainable Supplier Assessment Tenderers must have completed the Evergreen Sustainable Supplier Assessment and achieved Level 1 or above within 12 months prior to the Tender Close Date. Guidance and access are available at: https://www.england.nhs.uk/nhs-commercial/central-commercialfunction-ccf/evergreen • Carbon Reduction Plan (CRP) Tenderers must provide a valid Carbon Reduction Plan (CRP) link on their website that meets the requirements of PPN 006. • Cyber Security Tenderers that handle patient or personal data, or provide IT systems, services, or devices, must either: • hold a valid Cyber Essentials Plus Certificate; or • where the Tenderer does not have a Cyber Essentials Plus Certificate, submit a completed Information Security Third Party Questionnaire (ISTPQ). • Distribution Agreements If tendering as a Distributor, the Tenderer must provide written evidence from the relevant Original Equipment Manufacturer(s) (OEM) confirming that they have rights to distribute goods for the Term as defined in the Framework Agreement Award Pack. If the Term is extended, Distributors must provide further written evidence from the OEM confirming that they have rights to distribute goods for the remaining Maximum Term as defined in the Framework Agreement Award Pack.

East Riding of Yorkshire Council (ERYC) is committed to achieving the best possible outcomes for all children, young people and families. This specification expresses the vision and strategic priorities to drive forward better outcomes for children, young people and families across the East Riding of Yorkshire (ERY) and aims to create and support an approach to meeting the needs of children, young people and families in the ERY. The Integrated Specialist Public Health Nursing Service (ISPHNS) will deliver the ERYC commissioned public health nursing services for children and young people aged minus 9 months to 19 (25) years (this includes the Public Health elements of the Healthy Child Programme (HCP) ) All ISPHNS will have universal service provision at their core, universal and targeted public health services are crucial to improving the health and well-being of all children, young people and their families. The universal reach of the ISPHNS provides invaluable opportunity from early in a child's life to identify families that are in need of additional support and children at risk of poor outcomes. The ERYC ISPHNS will be led by Specialist Community Public Health Nurses (SCPHN) and the elements will be delivered by a workforce consisting of appropriately trained and qualified staff. SCPHN are registered nurses or midwives with specialist additional training and registrations. The ISPHNS will provide integrated expert information, assessment and interventions for babies, children, young people and families. They will help enable them to make informed decisions that affect their health and wellbeing and will play a core role in improving the health outcomes of the East Riding eligible population and reducing health inequalities. Provider(s) will deliver and support an integrated approach to meeting the needs of C&YP, their families and the delivery of improved outcomes. Provider(s) of the ISPHNS will work in partnership with a variety of organisations; including but not limited to maternity services, local authority-provided or commissioned services, third sector, health, education, private, independent services, primary and secondary care services. Provider(s) of the ISPHNS will work with all appropriate agencies and stakeholders to achieve positive outcomes for Service Users, recognising that families may need support across the whole spectrum of services, including social care, education, health, police, voluntary organisations, safeguarding and others. Provider(s) will proactively demonstrate integrated working throughout the delivery of the ISPHNS to improve the wellbeing and life chances of every Service User.

NHS South West London Integrated Care Board (the Authority) is seeking to commission a Mental Health Support Team (MHST) service comprising 25 operational and developing MHSTs across the six boroughs. The service will provide prevention and early intervention mental health support through a standardised and equitable MHST offer, in accordance with the specified requirements, to improve access to care, reduce health inequalities, and deliver improved outcomes for children and young people across South West London. Procured through a competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023, the Authority intends to appoint a Lead Provider with overall accountability for the governance, management, and delivery of the service. The Lead Provider will oversee all operational and developing MHSTs across South West London and will be responsible for the mobilisation, delivery and service integration of future MHST teams required as part of the planned expansion to achieve 100% MHST coverage across South West London by December 2029. The decisions applicable to this Procurement will be made by the Authority. The Procurement is being managed by NHS London Commercial Hub (NHS LCH) hosted by NHS North East London, on behalf of the Authority, in connection with an Invitation to Tender (ITT) exercise that is being conducted, based on the competitive process under the Health Care Services (Provider Selection Regime) regulations 2023 ("the Regulations"(as amended). None of the references to "ITT", "Bid", or the use of the term "tender process", or any other indication, shall be taken to mean that the Authority intends to hold itself bound to any of the Regulations, save those applicable to PSR provisions regarding the Competitive Process. Further information regarding the Authority is available from: https://www.southwestlondon.icb.nhs.uk/ The lifetime Value of the contract is £89,916,960 excluding VAT. The contract term is for three (3) years with an option for extension of further three (1 + 1 + 1) years at the sole discretion of the Authority. The contract will start on 01/04/2027 and end 31/03/2030, if the 1 + 1 + 1 optional extensions are utilised the maximum contract end date will be 31/03/2033. The maximum duration of the contract is 6 years (72 months). Further details of the procurement, including service requirements are included in the procurement documents.

The contract is expected to initially be delivered for NHS-funded care in England and Wales, and publicly funded care in Jersey for a period of three years, at a maximum total budget of up to £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other Devolved Nations and/or Crown Dependencies, aspirational measures and discretionary inflationary uplifts (all of which will be defined in the service specification). The maximum budget ‘core’ value of £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT, excludes the potential two-year extension and aspirational intent as included in section 14.4 of Annex A - Service Specification The contract may be extended for up to 24 months at a pro rata value of the core three- year funding, estimated at up to £518,877 excluding VAT. This proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first three years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year three, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year. Further to this funding, the specification contains a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, including the potential two- year extension and core 3 year value means an overall ceiling value for this contract of up to £6,417,788 excluding VAT and £7,701,346 including VAT. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures listed in section 14.4 of Annex A - Service Specification The role of a national clinical audit is to stimulate healthcare quality improvement through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against available national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals who are engaging with and using the audit results are also in a position to improve the system, and where there is a shared understanding of what good care looks like. National clinical audits are expected to: a.Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national healthcare quality improvement. b.Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience. c.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate. d.Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting. e.Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit. f.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future and plan for these linkages from the inception of the contract. g.Ensure robust methodological and statistical input at all stages of the audit. h.Identify from the outset the full range of audiences for the reports and other audit outputs and plan and tailor them accordingly. i.Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data. j.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget. k.Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services. l.Deliver high-quality audit outputs, benchmarking and quality improvement as a priority. At the time of writing the specification, requirements include (but please also refer to the potential future aspirational intent section): 1. Audit Purpose The overall ambition of the audit is to continue to capture and report data on the performance of individual healthcare providers against the National Institute for Health and Care Excellence (NICE) Quality Standard QS33: Rheumatoid Arthritis in Adults, Quality standard QS214: Rare diseases, and other relevant national standards and guidance, (see Appendix 1). 2. Paediatric Inflammatory Arthritis Pathway The supplier should work with the wider Dataset and Methodology Stakeholder Group to develop, maintain and report against a minimum viable paediatric inflammatory arthritis pathway. The initial focus should be on establishing a clinically meaningful dataset and reporting framework sufficient to describe the patient pathway and support audit activity. Initial measures should focus on a limited number of priority areas agreed with funders and stakeholders, for example referral, diagnosis and treatment timelines. The updated GIRFT Paediatric Inflammatory Arthritis Pathway guidance, anticipated for publication in January 2027, should be considered a key reference for the future development of the dataset, measures and reporting framework. The supplier should work with the wider Dataset and Methodology Stakeholder Group to review and align the dataset, metrics and reporting outputs with the recommendations and standards set out within the GIRFT guidance, ensuring ongoing relevance and consistency with national best practice. Any expansion beyond the core pathway, including additional metrics, PROMs/PREMs, transition measures and broader pathway development, should be considered future aspirational intent subject to feasibility, resources and further funding. 3. Data Collection and Audit Design The supplier should continue to deliver a continuous prospective clinical audit and work with the Dataset and Methodology Group to ensure the audit dataset remains clinically relevant and proportionate. The supplier is expected to collaborate with specialist disease-specific clinical groups to support interpretation of findings and improve case ascertainment and recruitment rates. 4. Organisational Survey and Quality Improvement The supplier should review and maintain the organisational survey to ensure it remains proportionate and aligned with audit objectives. Priority should be given to maximising analysis and utilisation of existing data rather than increasing data collection burden in collaboration with the wider Dataset and Methodology Stakeholder Group. The organisational survey should support the audit's quality improvement objectives by enabling a deeper understanding of service delivery, workforce capacity, variation in practice and barriers to high-quality care. 5. Benchmarking and Improvement The audit is expected to support continuous improvement across all services. While identifying high-performing and outlier services remains important, the audit should also support improvement among services performing at or around the national average, where the greatest overall gains may be achieved. Benchmarking should encourage year-on-year improvement within individual services and provide meaningful insights that motivate all providers to improve, regardless of their current position relative to national performance. 6. Targeted improvement support The supplier should provide targeted quality improvement support following each annual audit cycle. Activities should build on existing professional networks, collaboratives and stakeholder infrastructure wherever possible rather than creating wholly new arrangements. Improvement support should be designed to benefit healthcare providers across the performance spectrum, including those performing at a middle level where the greatest overall gains may be achieved, while also supporting services experiencing significant challenges or demonstrating exceptional practice. Learning generated through quality improvement activities should be shared with all participating healthcare providers to maximise the impact of the audit programme. The anticipated outputs are: 1.Near real-time dynamic and interactive metric results. 2.Publication of an annual state of the nation report with the inclusion of an organisational survey. 3.Incorporation of validated Patient Reported Outcome Measures. 4.Quality improvement resources. 5.The identification and notification of outliers. For further information on the current audit, currently delivered by the British Society for Rheumatology (BSR) please head to: https://www.rheumatology.org.uk/improving-care/audits/neiaa

Gloucestershire Health and Care NHS Foundation Trust ("the Authority") is seeking to appoint a suitably qualified and experienced provider for the delivery of Physical Pharmacy Services across its Physical Health services within Gloucestershire. The Authority delivers a diverse range of community-based, outpatient, rehabilitation, intermediate care, and inpatient physical healthcare services. The successful contractor will be required to provide a comprehensive, safe, effective, and patient-centred pharmacy service that supports the delivery of high-quality clinical care, medicines optimisation, and statutory compliance across the Trust's physical health portfolio. The service will be expected to provide expert pharmacy support, including but not limited to medicines management, medicines optimisation, clinical pharmacy input, governance and assurance activities, medicines reconciliation, prescribing support, staff training and education, audit and quality improvement activities, and specialist pharmaceutical advice to multidisciplinary teams. The Authority is seeking a provider that can demonstrate: Extensive experience in delivering pharmacy services within NHS and/or comparable healthcare environments; Strong clinical governance and medicines safety arrangements; - A skilled and resilient workforce capable of supporting services across multiple care settings; - The ability to work collaboratively with clinical teams and system partners; - Innovative approaches to medicines optimisation and service improvement; - Robust digital capabilities, reporting arrangements, and data management processes; and - A commitment to delivering high-quality patient outcomes, value for money, sustainability, and social value. The contract will support the Authority's strategic objectives by ensuring that patients receive safe, effective, and timely pharmaceutical care, while promoting the appropriate use of medicines and supporting service efficiency across physical healthcare pathways. The procurement will be conducted through an open and transparent competitive process. Tender submissions will be evaluated on the basis of the Most Advantageous Tender (MAT), taking into account quality, service delivery, clinical governance, social value, and commercial considerations. Full details of the evaluation methodology and award criteria will be provided within the procurement documentation. The successful provider will be expected to mobilise and maintain a service model that is responsive to changing patient needs, workforce challenges, regulatory requirements, and developments in pharmacy practice throughout the contract term. Further information relating to the scope of services, contract requirements, performance standards, Key Performance Indicators (KPIs), and contractual arrangements will be included within the Invitation to Tender documentation. Registration and documentation will be available for suppliers on Monday 21st September 2026.

Non-exclusive framework agreement for the supply of Medical Pulp Associated Products via the Stock, eDirect and Direct route to market. This includes but is not limited to; a range of products that are used to assist with the toileting of patients, collection of samples and aid the administration of procedures. The ranges of products available under the framework agreement include; Disposable Medical Pulp, Medical Pulp support products, Macerators, Bedpan Washers and Absorbent products for use with Medical Pulp. This framework agreement is for a total of 48 months. Precise quantities are unknown, however, it is anticipated that expenditure will be in the region of £120,000,000 ex VAT / £144,000,000 inc VAT throughout the duration of this framework agreement. This is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement.

YPO are looking for Suppliers to be appointed onto a Framework Agreement following a Competitive Tendering Procedure for the supply of Community & Healthcare Technology Equipment & Associated Services to the public sector. This Framework is designed to meet the needs of all public sector Contracting Authorities which includes YPO's internal requirements by establishing an agreement where the end customer will place the order with the Supplier and the Supplier will deliver direct to the end customer.

This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales.

Provision of Private Ambulance Services for Emergency (A&E/Blue Light)

NHS Birmingham and Solihull ICB are seeking providers who have the relevant experience and skills to provide a Dementia Support Service. This is a re-issue of this opportunity following a previously abandoned process. The contract term has been extended to 3 years with the option to extend for up to a further 3 years and an additional value of £80,000 of non-recurrent funding is being offered within year one of the contract on top of the annual value of £834,000 excluding VAT. Service aims: *To provide a single point of access for information and advice about dementia, information about what support is available pre- and post-diagnosis, and how to access this support: i. Signposting to other support services available and community groups relevant to the needs and interest of the individual. ii. Practical emotional support to promote greater emotional resilience in individuals by creating a sense of safety and an atmosphere of calm. iii. Practical coaching and support to people with dementia and their carers tailored to their situation, around best strategies and good practice to live well with the condition. iv. Advise on and facilitate access to peer-led group support. *To improve quality of life for individuals living with dementia and their carers through timely, person-centred support. *To develop a robust and clear working referral pathway in and out of service. The contract will be for a period of 3 years, commencing 1st April 2027, with the option to extend for up to a further 3 years. The annual value is £834,000 with an additional £80,000 of non-recurrent funding in year one, excluding VAT. Please refer to the procurement documentation for further details. To register your interest and access the procurement documentation and submit a bid, please follow this link: https://atamis-1928.my.site.com/s/Welcome, and search for: Project Reference: C472969

The Authority is seeking to appoint a Supplier to provide maintenance, support, supply, break/fix and relocation services for its IT and Estates passive cabling infrastructure, including copper, fibre and telephony cabling, together with associated communications cabinets. The requirement also includes support for traditional telephony cabling infrastructure. The Supplier must be able to demonstrate relevant experience in the delivery, maintenance and support of both traditional passive infrastructure networks and Passive Optical LAN (POLAN) environments.

NHS Devon Integrated Care Board (the Commissioner) is seeking to reopen the Framework Agreement and appoint suitable providers who have the capability and capacity to deliver the following services: LOT 1 - Live-in Care at Home for All-Ages LOT 2 - Complex Care for All-Ages LOT 3 - Trusted Assessors for Spot Therapy and Clinical Psychology Provision (SEND) The geography covered is that of NHS Devon ICB. 4) The framework agreement was established on 12th January 2026 for a period of 4 years ending on 11th January 2030. 5) The combined maximum value of the Framework Agreement is £61,297,064 for the 4-year period LOT 1 - Live-in Care at Home for All-Ages - £2,757,224 LOT 2 - Complex Care for All-Ages - £56,091,840 LOT 3 - Trusted Assessors for Spot Therapy and Clinical Psychology Provision - £2,448,000 Providers already admitted to the Framework do not need to reapply. Previous Unsuccessful Bidders to the Framework Agreement are able to apply again. This exercise is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioner.

North of England Commissioning Support (NECS) is a commissioning support service working for and on behalf of NHS North East and North Cumbria Integrated Care Board (the Relevant Authority) who are undertaking a competition to provide. Alternative Provider Medical Service (APMS) to be delivered for patients of Sunderland. Contract Start Date: 15 April 2027 Contract End Date: 14 April 2036 The contract term is for an initial period of 7 years, with an option to extend for a further 2 years at the discretion of the Relevant Authority and subject to satisfactory contractual and financial performance.

UK Sport is seeking a suitably qualified supplier to deliver its Athlete Medical Scheme, providing timely, high-quality healthcare to eligible funded athletes. Tenderers may propose a fully insured model, a trust-based model, or both. The contract will cover the administration and management of the scheme, access to an appropriate healthcare provider network, claims handling, management information and performance reporting. The contract will commence on 1 April 2027 for an initial three-year term, with the option to extend for a further year. Please see more detail in the ITT.

NHS Supply Chain is preparing a national framework agreement that will support the procurement of dental consumables, clinical solutions, equipment, digital technologies, diagnostics, and practice infrastructure, structured across the following indicative lots: The following lot structure is indicative and subject to final confirmation: Lot 1: Dental Consumables & Appliances Lot 2: Specialist Clinical & Bespoke Solutions Lot 3: Operatory Equipment Lot 4: Dental Laboratory & Digital Solutions Lot 5: Dental Imaging & Diagnostics Lot 6: Dental Environment, Decontamination & Practice Building Lot 7: Mobile Dental Clinics & Equipment Note: For future tenders the following requirements will apply: • ISO Certification: Tenderers must have ISO 9001: 2015 or BS EN ISO 13485:2016 certification or Medical Device Single Audit Program (MDSAP) certification accredited by the United Kingdom Accreditation Service (UKAS) (or international equivalent) to cover all segments of the Tenderer’s and the product’s supply chain. This should include, but not be limited to, sales, manufacturing, storage and distribution ('ISO Certification'). Link for acceptable alternatives https://iaf.nu/en/accreditation-bodies/ (‘Notified Bodies’). • CE Certification and Declaration of Conformity certificates are required where applicable to be presented at submission stage of the tender. • Modern Slavery for Tenderers that have an annual turnover of at least £36 million must have a link to their modern slavery statement on their website • Modern Slavery Assessment Tool (MSAT) Tenderers must have a score of 41% or above within 12 months of the Tender Publication Date via https://supplierregistration.cabinetoffice.gov.uk/ • Evergreen Sustainable Supplier Assessment – Tenderers will need to have completed the assessment and achieved Level 1 within the 12 months prior to the Tender Close Date. Link for instructions and access for this assessment: https://www.england.nhs.uk/nhs-commercial/central-commercial-function-ccf/evergreen/ • Carbon Reduction Plan (CRP): Tenderers must have a valid CRP link on their website that meets the requirements of PPN 006 as outlined in the PPN, OR Where Supplier has no website, the CRP is provided in PDF format that meets the requirements of PPN 006 as outlined in the PPN, OR Excused in exceptional circumstances. • Cyber Security: If you handle patient or personal data, or provide any IT systems, services, or devices you will need to have a Cyber Security Essentials Plus Certificate.

This Dynamic Market will be for the supply of ultra-low-field magnetic resonance imaging (ULF MRI) systems and associated goods. The Dynamic Market may include, but is not limited to, ULF MRI scanners, imaging and reconstruction software, operator workstations, radiofrequency coils, accessories, peripherals, spare parts, replacement components, consumables and ancillary equipment. Systems may be fixed, mobile, transportable or portable and suitable for deployment across healthcare, diagnostic, community, research and point-of-care settings. The Dynamic Market may also include software licences, system upgrades and other goods required for the installation, operation and maintenance of ULF MRI systems.

The London Borough of Bromley is recommissioning the Bromley 0 -19 Children's Public Health Nursing Service. The aim of the 0-19 Public Health Nursing Service is to deliver the Healthy Child Programme for Children and Young People aged 0-19 and plays a critical role in supporting the health, well-being and development of children, young people and families. The Service includes health visiting and school nursing provision, delivering key public health priorities. It is the Council's intention to award a single contract to one provider. The procurement will be undertaken using the Competitive Procedure of the Provider Selection Regime. The contract will commence on 1st October 2027 for a period of 5 years to 30th September 2032.

The proposed Framework will provide access to specialist teleradiology, radiology workflow management, telepathology, teledermatology, telemicrobiology and teleophthalmology services, reflecting the growing role of digital technologies in supporting healthcare delivery. Each service area will be established as a separate lot, enabling NHS organisations in Scotland and Northern Ireland to procure services in accordance with their specific clinical requirements and service needs.

Project title: NHS National Framework for Pertuzumab Offer reference number: CM/TNS/26/5765 Period of framework: 1 August 2027 to 31 August 2028 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

County Durham and Darlington NHS Foundation Trust (CDDFT) are seeking to appoint a single supplier to provide Teleradiology Reporting Services. The Trust operates across two large acute sites and several non-acute sites, serving the population of County Durham and Darlington. At County Durham and Darlington NHS Foundation Trust, our vision is to deliver care which is right first time, every time. We are guided by our core values of respect and dignity, compassion, quality care, improving lives, everyone counts and working together for patients. By placing people and communities at the heart of all that we do, we strive to create a supportive and inclusive environment for both patients and our workforce, ensuring that every individual receives safe, compassionate and joined-up care. Reporting requirements will include but are not limited to: MRI, CT, Plain Film, Nuclear Medicine, with limited reporting requiring Specialist Radiologists. The Trust are seeking a supplier who is able to provide reporting services twenty-four hours a day, seven days a week for Urgent and Emergency Radiology Reporting, as well as provide Elective Reporting. There is no volume commitment as part of this contract and the demand from the Trust may vary overtime dependent on in house reporting capacity. However, the supplier would hold an exclusive contract for the out of hours provision to maintain continuity on the basis that the supplier can meet the turnaround time outlined by the Trust. However, for all other reporting, the Trust will be able to use alternative suppliers if desired. As demand fluctuates, the supplier must be able to adapt to high and low demands for reporting services. Bidding suppliers will be evaluated in line with the below Provider Selection Regime (PSR) Key Criteria regulated scoring: 1: Quality and Innovation: 20% 2: Improving Access, Reducing Health Inequalities and Facilitating Choice: 15% 3: Integration, Collaboration and Service Sustainability: 15% 4: Value - Price: 40% 5: Social Value: 10%